Analysis of the Global Human Albumin Market and Product Pipeline : Emerging Economies and Use of Human Albumin as an Excipient Present New Growth Opportunities
Executive Summary—Key Findings
- The global human albumin demand is likely to grow at a moderate rate of % during 2013?2020 driven by the use of albumin as a drug formulation agent, sealant, medical coating, and as an imaging and vaccine stabiliser. - Human albumin production is driven by the global increase in fractionation of blood and the rising demand for human albumin in Asia-Pacific (APAC) nations such as China and India. - The human albumin market is highly consolidated and dominated by top participants, namely, CSL Behring, Grifols, Kedrion, Octapharma, and Biotest. Manufacturers are likely to adopt premium pricing to meet the emerging demand for human albumin in the non-therapeutic segment. - The human albumin market is characterised by advancements in the use of human albumin protein as a vehicle for the delivery of drugs and extension of the shelf life of drugs/biologics. - These innovations are revolutionising the standard treatment regimen by reducing the requirement for additional doses or injections, better tolerance, and improved efficacy of the drug action. - Human albumin has been widely used in clinical settings as a plasma expander or as replacement therapy. However, for over a decade, the use of human albumin as a non-therapeutic substance/excipient, that is, as a drug carrier, stabilising agent in vaccine, and as a sealant in surgeries and coatings in medical devices and diagnostic kits is being explored and developed for commercial settings.
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• Sep 2021
Major players in the autoinjectors market are AbbVie, Mylan, Eli Lilly and Company, Amgen, Becton Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical, Merck, Pfizer, Bayer, Biogen, and AstraZeneca. The global autoinjectors market is expected to grow from $2.42 billion in 2020 to $2.94 billion in 2021 at a compound annual growth...
Drug Delivery Technologies: Market Size From $1,451.50 billion in 2020, the global Drug Delivery Technologies market is projected to reach $3,203.09 billion by 2028. Based on our analysis the market is expected to grow at a CAGR of 10.4% from 2020 - 2028 timeframe. Some of the prominent trends that the market...
The global isosorbide market exhibited moderate growth during 2015-2020. Also known as D-Isosorbide dinitrate, isosorbide (C6H10O4) is a bio-product obtained from starch. The derivatives of isosorbide, namely isosorbide dinitrate and isosorbide mononitrate, find extensive applications across various end use industries...
Report Scope This report analyzes the market trends of microneedles with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through the forecast period of 2021 to 2026). Regulatory scenarios, drivers, restraints and opportunities will be covered, as well as market shares for leading...
693 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Jul 2021
Drug Delivery Systems (DDS) are the advanced formulations or technologies that modulate the release profile of therapeutic or prophylactic agents, their absorption, distribution and elimination characteristics to achieve the desired therapeutic effect and enhance the safety profile, patient convenience and compliance to medications...
Forecasts by Technology (Oral Drug Delivery Therapy, Injectable Drug Delivery, Topical Drug Delivery, Pulmonary Drug Delivery, Implantable Drug Delivery, Ocular Drug Delivery, Others), by Indication (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Others), by Distribution...
Microspheres: Market Size From $5.62 billion in 2020, the global Microspheres market is projected to reach $12.96 billion by 2028. Based on our analysis the market is expected to grow at a CAGR of 11.0% from 2020 - 2028 timeframe. Some of the prominent trends that the market is witnessing include, emerging economies...
Gene therapy: More than half of industry revenue is generated by sales of healthcare products Abstract Biotechnology in the US The Biotechnology industry is growing quickly, characterized by a multitude of product applications and a wide range of burgeoning markets. Growing demand for ethanol indicates...
This report aims to provide a comprehensive study of the global market for transdermal drug delivery technologies/systems. It provides a detailed description of the different types of transdermal drug delivery systems (passive and active) and the current and historical market revenues.
539 pages •
By Roots Analysis Private Ltd.
• Jun 2021
Around 90% of the drug candidates in the current development pipeline and close to 40% of marketed pharmacological products, have been associated with concerns related to solubility and / or permeability. , In this context, considering modern regulatory standards, a large number of potential therapeutic leads...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.